Health Teclistamab Shows Promise for Multiple Myeloma Patients Unfit for Trials Data reveals that teclistamab-cqyv, a novel T-cell-engaging bispecific antibody, may significantly benefit numerous patients with multiple myeloma who were previously ineligible for pivotal clinical... Editorial10 hours ago